by CheckRare Staff | May 10, 2024
Katie Abouzahr, MD, Vice President, Autoantibody Portfolio and Maternal Fetal Disease Area Leader at Johnson & Johnson, discusses nipocalimab for the treatment of myasthenia gravis and other autoantibody diseases. Myasthenia gravis (MG) is a chronic...
by Madaline Spencer | May 8, 2024
Alan Percy, MD, Pediatric Neurologist at University of Alabama at Birmingham, describes the history of Rett syndrome. Rett syndrome is a neurodevelopmental condition primarily affecting girls. Patients with the disease appear to have normal psychomotor...
by James Radke, PhD | May 7, 2024
Alessio Di Fonzo, MD, PhD, neurologist at the University of Milan, discusses research looking into the connection between Gaucher disease and Parkinson’s. Gaucher Disease Gaucher disease refers to a group of inherited metabolic diseases in which harmful...
by Madaline Spencer | May 6, 2024
Benjamin Barnes, MD, Augusta University, discusses how he approaches ALS patient conversations and an ongoing platform trial. Amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig’s disease, is a motor neuron disease which leads to...
by Madaline Spencer | May 3, 2024
Sean Studer, MD, MSc, FCCP, Head of Medical Affairs at the US Pulmonary Hypertension Group, at Johnson & Johnson, discusses the changing treatment landscape of pulmonary arterial hypertension (PAH), including the approval of Opsynvi (macitentan plus tadalafil)....
